A Systematic Review on Epidemiology, Risk Factors, Diagnosis & Treatment Associated with Melanoma Ulcer

After tumor thickness and mitotic activity, ulceration is the third most potent predictor of survival in the AJCC Melanoma Staging System and is linked to poor clinical outcomes. Males have a higher incidence of ulcerated melanoma, which also rises with age and systemic inflammatory risk factors (high body mass index, smoking, diabetes, and low vitamin D). A key component of the American Joint Committee on Cancer's (AJCC) recently updated melenoma staging system is the pathologists' evaluation of ulceration. When comparing ulcerated melanomas to non-ulcerated lesions for thickness and disease stage, the survival rates were still lower for ulcerated melanomas. We used systems biology to investigate the role of host and tumor-specific processes in determining the phenotype of ulcerated melanomas, which were thicker and more mitotically active (with corresponding transcriptomic upregulation of cell cycle pathways). Consumption of the epidermis (COE), also known as ulcerated lesions, is associated with ulcerated lesions and correlates with increased tumor cell proliferation.